The DOI matches its Crossref record.
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.
Open accessAbstract
We studied the localization of latent transforming growth factor-beta 1 (TGF-beta 1) and its binding protein (LTBP-1) in the extracellular matrix of cultured human fibroblasts by immunofluorescence and immunoelectron microscopy. Immunofluorescence of confluent fibroblast cultures indicated that LTBP-1 localizes to extracellular fibrillar structures resembling fibronectin-collagen matrix. Similar fibrillar structures were detected in cells stained with antibodies specific for TGF-beta 1 propeptide (beta 1-LAP). Both LTBP-1 and beta 1-LAP colocalized with fibronectin in double immunofluorescence analysis. These fibrillar structures were resistant to extraction with sodium deoxycholate, which is further evidence that LTBP-1 and large latent TGF-beta 1 complexes are integral components of the extracellular matrix. SV-40-transformed human fibroblasts lacked extracellular LTBP-1 fibers. EM analysis revealed approximately 10-nm-thick microfibrils that were labeled by anti-LTBP at 90-140-nm intervals. In addition, LTBP-1 was found in structures that were heavily labeled for fibronectin. The accumulation of LTBP-1 in the fibronectin matrix could be reconstituted in vitro. When isolated matrix components were immobilized on nitrocellulose and incubated with fibroblast conditioned medium, LTBP-1 from the medium associated with cellular fibronectin but not with heparan or chondroitin sulfate, vitronectin, tenascin, laminin, or collagen I or IV. The association of LTBP-1 with cellular fibronectin was abolished by treatment of the medium with plasmin, which cleaves LTBP-1 and inhibits its assembly to matrix. The present results indicate that latent TGF-beta 1 complexes are components of the extracellular matrix and suggest that alterations of the pericellular matrix could result in aberrant TGF-beta signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., & Dietz, H. C. (2003) · Nature Genetics · doi:10.1038/ng1116 · Cited by 1,404
Kielty, C. M., Sherratt, M. J., & Shuttleworth, C. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2817 · Cited by 841
The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology
Liu, A. C., Joag, V. R., & Gotlieb, A. I. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070251 · Cited by 632
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1
Pereira, L., Lee, S. Y., Gayraud, B., Andrikopoulos, K., Shapiro, S. D., Bunton, T., Biery, N. J., Dietz, H. C., Sakai, L. Y., & Ramirez, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3819 · Cited by 549
Isogai, Z., Ono, R. N., Ushiro, S., Keene, D. R., Chen, Y., Mazzieri, R., Charbonneau, N. L., Reinhardt, D. P., Rifkin, D. B., & Sakai, L. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209256200 · Cited by 548
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Walton, K. L., Johnson, K. E., & Harrison, C. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00461 · Cited by 543
Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability
Rifkin, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r400029200 · Cited by 420
Gruber, H. E., & Hanley, E. N. (1998) · Spine · doi:10.1097/00007632-199804010-00001 · Cited by 415
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Yutzey, K. E., Demer, L. L., Body, S. C., Huggins, G. S., Towler, D. A., Giachelli, C. M., Hofmann-Bowman, M. A., Mortlock, D. P., Rogers, M. B., Sadeghi, M. M., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.302523 · Cited by 371
Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation
Hyytiäinen, M., Penttinen, C., & Keski-Oja, J. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490460933 · Cited by 354
Self-citationNakajima, Y., Yamagishi, T., Hokari, S., & Nakamura, H. (2000) · The Anatomical Record · doi:10.1002/(sici)1097-0185(20000201)258:2<119::aid-ar1>3.0.co;2-u · Cited by 317
Dallas, S. L., Sivakumar, P., Jones, C. J. P., Chen, Q., Peters, D. M., Mosher, D. F., Humphries, M. J., & Kielty, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410762200 · Cited by 316
Saharinen, J., Hyytiäinen, M., Taipale, J., & Keski-Oja, J. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00010-6 · Cited by 315
Self-citationThe molecular genetics of Marfan syndrome and related microfibrillopathies
Robinson, P. N., & Godfrey, M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.9 · Cited by 311
TGF‐β Latency: Biological Significance and Mechanisms of Activation
Gleizes, P., Munger, J. S., Nunes, I., Harpel, J. G., Mazzieri, R., Noguera, I., & Rifkin, D. B. (1997) · STEM CELLS · doi:10.1002/stem.150190 · Cited by 266
Latency, activation, and binding proteins of TGF-?
Koli, K., Saharinen, J., Hyyti�inen, M., Penttinen, C., & Keski-Oja, J. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<354::aid-jemt1020>3.0.co;2-g · Cited by 261
Self-citationSterner-Kock, A., Thorey, I. S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski-Oja, J., et al. (2002) · Genes & Development · doi:10.1101/gad.229102 · Cited by 256
Self-citationTenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Alcaraz, L. B., Exposito, J.-Y., Chuvin, N., Pommier, R. M., Cluzel, C., Martel, S., Sentis, S., Bartholin, L., Lethias, C., & Valcourt, U. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201308031 · Cited by 94
“Depending on the cell context, the latter mechanism might involve either various cell surface receptors, such as RGD-dependent integrins (Wipff and Hinz, 2008), or the ECM protein thrombospondin 1 (TSP-1; SchultzCherry and Murphy-Ullrich, 1993).”
Influential
Metadata
- Authors
- Taipale, J., Saharinen, J., Hedman, K., & Keski-Oja, J.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 1996-08
- Volume
- 44
- Issue
- 8
- Pages
- 875-889
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W2013701595
- Cited by
- 224
- References
- 0
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.